Denise Robertson, chief operating officer at Northern Iowa Therapy, has been recognized in the Business Partner category of the 2023 McKnight’s Pinnacle Awards.
LTC ACO shares $20.6 million in savings with participating providers
By
Kathleen Steele Gaivin
Mar 20, 2023
LTC ACO has received a positive reconciliation and settlement under the Medicare Shared Savings Program for the 2021 performance year, earning shared savings of $20.6 million at the maximum enhanced track...
New alert system makes sure seniors with hearing impairment receive emergency warnings loud and clear
By
Aaron Dorman
Jan 09, 2024
A new emergency alert system targets seniors who are hard of hearing, combining bright flashing lights and louder-than-normal alarms.
Finger prick, venous blood can ID key Alzheimer’s disease biomarkers
Jul 20, 2023
Capillary and venous dry blood spot can identify glial fibrillary acidic protein, neurofilament light and phosphorylated tau.
Resident found on bus died of hyperthermia complications, coroner says
By
Lois A. Bowers
Nov 15, 2016
Complications of hyperthermia were responsible for the death of an 84-year-old senior living resident whose body was found on her community’s travel bus the day after she went on an outing with fellow...
A $60 million lawsuit alleging understaffing and fraudulent billing at 45 senior living communities in North Carolina “is an erroneous interpretation of Medicaid reimbursement in the state,”...
Senior living executive settles in $3.9 million SEC fraud case
By
Lois A. Bowers
Jul 12, 2017
A South Carolina businessman has settled with the Securities and Exchange Commission after being charged in January in a $3.9 million fraud case for allegedly diverting investor funds meant to buy or renovate...
Alzheimer’s cure would result in assisted living losses of $16 billion in annual revenues, 110,000...
By
Lois A. Bowers
Sep 17, 2019
A “novel, simple and fast-acting” cure for Alzheimer’s disease would be a “medical miracle” but would result in a loss of $16.3 billion in annual revenues for the assisted living industry, according...
Plasma biomarkers identified for detecting presymptomatic Alzheimer’s disease
Jan 13, 2023
Plasma P-tau181, NfL and GFAP concentrations were higher in mutation carriers versus noncarriers of autosomal dominant Alzheimer’s disease.
Experimental drug for Alzheimer’s disease slows decline in thinking
May 03, 2023
Eli Lilly says the drug slows memory and thinking declines in early symptomatic Alzheimer’s disease patients by more than a third.